Ryman Healthcare Ltd logo

Ryman Healthcare Ltd

NZSE:RYM (New Zealand)   Ordinary Shares
NZ$ 3.64 (-0.55%) May 31
522.86
P/B:
0.57
Market Cap:
NZ$ 2.50B ($ 1.54B)
Enterprise V:
NZ$ 5.03B ($ 3.09B)
Volume:
2.34M
Avg Vol (2M):
1.93M
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Ryman Healthcare Ltd ( NZSE:RYM ) from 1999 to May 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ryman Healthcare stock (NZSE:RYM) PE ratio as of May 31 2024 is 522.86. More Details

Ryman Healthcare Ltd (NZSE:RYM) PE Ratio (TTM) Chart

To

Ryman Healthcare Ltd (NZSE:RYM) PE Ratio (TTM) Historical Data

Total 1207
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Ryman Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-01 520.0 2024-03-27 10.9
2024-05-31 520.0 2024-03-26 10.9
2024-05-30 522.9 2024-03-25 10.9
2024-05-29 515.7 2024-03-22 11.3
2024-05-28 530.0 2024-03-21 11.3
2024-05-27 545.7 2024-03-20 11.3
2024-05-24 557.1 2024-03-19 11.4
2024-05-23 557.1 2024-03-18 11.4
2024-05-22 542.9 2024-03-15 11.4
2024-05-21 561.4 2024-03-14 11.4
2024-05-20 571.4 2024-03-13 11.4
2024-05-17 560.0 2024-03-12 11.5
2024-05-16 585.7 2024-03-11 11.4
2024-05-15 538.6 2024-03-08 11.1
2024-05-14 542.9 2024-03-07 11.1
2024-05-13 521.4 2024-03-06 10.9
2024-05-10 524.3 2024-03-05 11.0
2024-05-09 538.6 2024-03-04 11.4
2024-05-08 550.0 2024-03-01 11.2
2024-05-07 557.1 2024-02-29 11.5
2024-05-06 555.7 2024-02-28 11.4
2024-05-03 562.9 2024-02-27 11.0
2024-05-02 574.3 2024-02-26 11.4
2024-05-01 580.0 2024-02-23 11.6
2024-04-30 581.4 2024-02-22 11.7
2024-04-29 608.6 2024-02-21 11.3
2024-04-26 592.9 2024-02-20 11.3
2024-04-24 608.6 2024-02-19 12.1
2024-04-23 604.3 2024-02-16 13.6
2024-04-22 625.7 2024-02-15 13.6
2024-04-19 628.6 2024-02-14 13.6
2024-04-18 631.4 2024-02-13 13.6
2024-04-17 635.7 2024-02-12 13.6
2024-04-16 634.3 2024-02-09 13.7
2024-04-15 642.9 2024-02-08 13.9
2024-04-12 642.9 2024-02-07 14.1
2024-04-11 642.9 2024-02-05 14.1
2024-04-10 642.9 2024-02-02 14.2
2024-04-09 640.0 2024-02-01 14.3
2024-04-08 652.9 2024-01-31 14.1
2024-04-05 642.9 2024-01-30 14.2
2024-04-04 640.0 2024-01-29 14.3
2024-04-03 650.0 2024-01-26 14.4
2024-04-02 650.0 2024-01-25 14.3
2024-03-28 650.0 2024-01-24 14.2

Ryman Healthcare Ltd (NZSE:RYM) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Ryman Healthcare develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Most of its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.